Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Viking Therapeutics Inc | 0.640% | -7.424% | 4.335% | 191.961% | 255.162% | 1177.778% | - |
| Eli Lilly Corp. | 0.680% | 2.491% | 5.649% | 75.867% | 36.364% | 341.176% | 594.712% |
| Vertex Pharmaceuticals Inc. | -0.800% | 3.337% | 11.264% | 30.245% | 10.830% | 132.580% | 176.591% |
| Intra-Cellular Therapies Inc. | -0.830% | -1.626% | -11.029% | 4.131% | -7.209% | 97.712% | 431.168% |
| Healthequity Inc. | - | 1.399% | -3.974% | 38.095% | 21.849% | 13.815% | - |
| Cardiff Oncology Inc. | -4.060% | 3.715% | -17.791% | 114.469% | 154.559% | -50.370% | -4.286% |
| Ocular Therapeutix Inc. | 0.760% | 9.091% | 16.200% | -4.803% | 35.558% | -50.966% | 87.661% |
| Revance Therapeutics Inc. | 2.880% | - | - | - | - | - | - |
| Agenus Inc. | -1.970% | - | - | - | - | - | - |
| Utah Medical Products Inc | -0.780% | - | - | - | - | - | - |